( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , 

 ISSN 2394-3211

Impact Factor: 6.222

 ICV - 79.57



Md. Shafiqul Islam*, Md. Arif Uddin, Md. Abdur Rahim, Kazi Mahzabin Arin, Raka Mustary Khan, AKM Akhtaruzzaman


Objective: The Objective of the study was to compare between haemodynamic variability and amount of sevoflurane consumption with cost analysis. Method: This double blinded randomized clinical trial was conducted among 120 patients aged 1-7 years undergoing routine elective paediatric day case surgery of under 60 minutes of duration at the Department of Anaesthesia, Analgesia and Intensive Care Medicine, BSMMU, Dhaka during the period of May 2018 to september 2018. Results: Majority patients were male (92.5%). Among group A patients, 90% were male and 10% were female. Whereas, among group B patients, 95% were male and 5% were females. Distribution of sex was similar across groups (p>0.05). Among all patients, majority belonged to ASA grade I (91.7%). Among group A patients, 93.3% were of ASA grade I and 6.7% were of grade II. Among group B patients 90% were of grade I and 10 % were of grade II. There were no statistically significant difference between groups (p>0.05). Peri-operative heart rate and blood pressure were significantly lower in group B patients in comparison to group A patients. Recovery profile was measured by modified Ramsay Sedation Score. Total volume percentage of anaesthetic gas required and mean volume percentage per min were significantly higher in Group A than group B (p<.001). Total volume of sevoflurane consumed, total cost of sevoflurane and per minute cost of sevoflurane were significantly lower in patients who were given midazolam as a premedication (group B) than those who were not given midazolam premedication (group A, p<.001 for each). The concentration of sevoflurane required during maintenance of anaesthesia was less. So total amount of sevoflurane was less required in experimental group. Adding the cost of oral midazolam tablet will contribute very insignificantly to the total cost. Conclusion: From our study we can say that premedication with midazolam provided better reduction in peri-operative anxiety, lesser consumption of sevoflurane in paediatric day case surgery with lower cost in these group compared to control.

Keywords: Haemodynamic, anaesthesia, sevoflurane, midazolam.

[Full Text Article]



  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 September 2023 Issue has been Published, Kindly check it on


    SEPTEMBER issue has been successfully launched on 1 SEPTEMBER 2023.

  • EJPMR New Impact Factor

    Its our Pleasure to Inform you that EJPMR Impact Factor has been increased from  5.804 to 6.222, due to high quality Publication at International Level

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI ) Scope Database